MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-HP-10-0006599
Mankind Life Sciences Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹83.68 Cr
▼ 7% YoY
Net loss · FY 2026
₹9.23 Cr
Net margin -11%
EBITDA · FY 2026
-₹8.24 Cr
EBITDA margin -9.8%
Authorised capital
₹190 Cr
Registered with MCA
Paid-up capital
₹177.51 Cr
Issued & subscribed
Open charges
₹20 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
125
Provident fund records
About Mankind Life Sciences Private Limited
Data last updated:
Mankind Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Mankind Pharma Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2020PTC369904. Its GSTIN is 07ABECS4493H3ZZ (Delhi). The company holds 23 GST registrations, of which 21 are active.
The company has an authorised share capital of ₹190 Cr and a paid-up capital of ₹177.51 Cr. It was formerly known as Saburi Digital Technologies Private Limited. It is led by directors including Mohammad Faisal Siddiqui (Whole-Time Director) and Akhlas Ahmed.
Its last annual general meeting (AGM) was held on 31 August 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 208 Okhla Industrial Estate Phase – III, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2026, the company reported a revenue of ₹83.68 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹9.23 Cr (net margin -11%) and EBITDA of -₹8.24 Cr (EBITDA margin -9.8%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years.
The company has about 125 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Mankind Pharma. As per MCA filings, the company has open charges of ₹20 Cr on record. Court records list 6 cases involving the company, including 5 filed by the company and 1 filed against it; 3 cases are pending. The company has 5 deals on record (2 rights issues, 2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹100 Cr; the latest was in December 2022.
Mankind Life Sciences Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-HP-10-0006599). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mankindpharma.com.
Company details
CIN U24100DL2020PTC369904
Registration Number 369904
Incorporation Date 14 September 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Parent Company Mankind Pharma Limited
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-HP-10-0006599
CIN history
Mankind Life Sciences has one previous CIN (Corporate Identification Number): U72900DL2020PTC369904. The current CIN is U24100DL2020PTC369904, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100DL2020PTC369904 | Current |
| U72900DL2020PTC369904 | Previous |
Recognitions & Rankings of Mankind Life Sciences
Contact details
Mankind Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Social Media
- Registered Address208 Okhla Industrial Estate Phase – III, New Delhi, Delhi, India – 110020
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Mankind Life Sciences Private Limited, buy the company report.
Comprehensive company report
Mankind Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Mankind Life Sciences operates one associated brand: Mankind Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | mankindpharma.com |
Business activity
The main business activity of Mankind Life Sciences is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Mankind Life Sciences Private Limited, buy the company report.
Financials of Mankind Life Sciences Private Limited
FY 2026 filings availableMankind Life Sciences Private Limited reported revenue of ₹83.68 Cr (down 7% YoY) for FY 2026.
Revenue · FY 2026
₹83.68 Cr ▼ 7%
Net loss · FY 2026
₹9.23 Cr margin -11%
EBITDA · FY 2026
-₹8.24 Cr margin -9.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▲ 57%
Revenue fell 7% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 19%. EBITDA rose 57% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹83.68 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹8.24 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹9.23 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9.8% | ||||
| Net Profit Margin | -11% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mankind Life Sciences Private Limited, buy the company report.
Board of directors of Mankind Life Sciences Private Limited
Mankind Life Sciences has 5 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akhlas Ahmed Also directs: Mankind Petcare Private Limited, Sirmour Remedies Private Limited, Mankind Medicare Private Limited and 5 more | Director | 17 Sep 2021 | 5 Years 1 Months | Current |
| Anil Kumar | Director | 17 Sep 2021 | 5 Years 1 Months | Current |
| Abhay Kumar Srivastava Also directs: Mankind Petcare Private Limited, Sirmour Remedies Private Limited, Mankind Medicare Private Limited and 5 more | Director | 17 Sep 2021 | 5 Years 1 Months | Current |
| Mohammad Faisal Siddiqui Also directs: Prolijune Lifesciences Private Limited | Whole-Time Director | 10 Sep 2026 | 0 Years 2 Months | Current |
| Meenakshi Agarwal | Director | 25 May 2026 | 0 Years 5 Months | Current |
Auditor
Mankind Life Sciences Private Limited is audited by Bhagi Bhardwaj Gaur & Co for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Bhagi Bhardwaj Gaur & Co | FY 2026 | 007895N |
Shareholding
The shareholding of Mankind Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mankind Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹20 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jun 2026 | 101331903 | Others | ₹20 Cr | Open |
Total charge records: 1 View all charges
Deals & funding
Mankind Life Sciences Private Limited has 5 deals on record (2 rights issues, 2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹100 Cr; the latest was in December 2022.
Total deals
5
Rights issues
2
Funding rounds
2
Secondary share transfer
1
Disclosed funding
₹100 Cr
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2022 | Funding round | ₹10 Cr | Investors: Mankind Pharma Limited |
| Oct 2022 | Rights issue | ₹7 Cr | Investors: Mankind Pharma Limited |
| Feb 2022 | Funding round | ₹90 Cr | Investors: Mankind Pharma Limited |
| Nov 2021 | Rights issue | ₹1.5 Cr | Investors: Mankind Pharma Limited |
| Sep 2021 | Secondary share transfer | Undisclosed | Buyer: Mankind Pharma Limited Seller: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Mankind Life Sciences Private Limited has 6 court cases on record: 5 filed by Mankind Life Sciences, 1 filed against it. 3 cases are pending and 3 are disposed.
Total cases
6
Filed by the company
5
Filed against the company
1
Pending
3
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 0 | 2 |
| Supreme Court | 1 | 1 | 1 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (Special Leave Petition (Civil)) | Filed against the company by State of Himachal Pradesh | Pending |
| High Court, HIMACHAL PRADESH | Writ petition | Filed by the company against Central Provident Fund Commissioner and Others(Not Applicable) and 2 others | Pending |
| High Court, HIMACHAL PRADESH | Interim or miscellaneous application | Filed by the company against Central Provident Fund Commissioner and Others(Not Applicable) | Pending |
| High Court, HIMACHAL PRADESH | Interim or miscellaneous application | Filed by the company against The State of HP and Another(Not Applicable) | Disposed |
| High Court, HIMACHAL PRADESH | Writ petition | Filed by the company against The State of HP and Another(Not Applicable) and 1 other | Disposed |
To see the full case history of Mankind Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mankind Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Mankind Life Sciences has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Upakarma Ayurveda Private Limited | U36999DL2017PTC326510 |
To see the full group structure of Mankind Life Sciences Private Limited, buy the company report.
Employees & EPFO
Mankind Life Sciences Private Limited has a workforce of 125 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
125
Active EPFO establishments
1
Employee growth
3.3%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 125 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Mankind Life Sciences Private Limited, buy the company report.
GST
Mankind Life Sciences has 23 GST registrations: 21 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
23
Active
21
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07ABECS4493H3ZZ | Delhi | Active | 13 Nov 2021 |
| 07ABECS4493H4ZY | Delhi | Active | 01 May 2022 |
| 09ABECS4493H1ZX | Uttar Pradesh | Active | 19 Nov 2021 |
| 29ABECS4493H1ZV | Karnataka | Active | 22 Dec 2021 |
To see the full GST registrations and return filing status of Mankind Life Sciences Private Limited, buy the company report.
Recent activity
Mankind Life Sciences Private Limited has 15 board changes on record since 2021: 6 appointments and 9 cessations. The latest: Mohammad Faisal Siddiqui was appointed as Whole-Time Director on 10 Sep 2026.
Appointed
Mohammad Faisal Siddiqui was appointed as Whole-Time Director.
AGM
Mankind Life Sciences Private Limited last Annual general meeting of members was held on 31 Aug 2026 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101331903 was registered on 24 Jun 2026.
Appointed
Meenakshi Agarwal was appointed as Director.
Filing
Mankind Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Delhi I.
Ceased
Sanjay Koul ceased to be CEO.
Ceased
Ashish Mittal ceased to be Company Secretary.
Ceased
Anju Kumari Jha ceased to be Additional Director.
Appointed
Sanjay Koul was appointed as CEO.
Ceased
Abhay Kumar Srivastava ceased to be Additional Director.
Ceased
Akhlas Ahmed ceased to be Additional Director.
Ceased
Anil Kumar Tyagi ceased to be Additional Director.
7 earlier events are in the company report.
News
Frequently asked questions
Mankind Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 September 2020 (6+ years old) and is registered under CIN U24100DL2020PTC369904.
Mankind Life Sciences has 5 current directors:
- Mohammad Faisal Siddiqui - Whole-Time Director
- Akhlas Ahmed - Director
- Anil Kumar - Director
- Abhay Kumar Srivastava - Director
- Meenakshi Agarwal - Director
The latest financial statements of Mankind Life Sciences on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 31 August 2026. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Mankind Life Sciences is 07ABECS4493H3ZZ, registered in Delhi. The company has 23 GST registrations in all, of which 21 are active and 2 are cancelled or inactive. Other active GSTINs include 07ABECS4493H4ZY (Delhi), 09ABECS4493H1ZX (Uttar Pradesh), 29ABECS4493H1ZV (Karnataka).
The CIN (Corporate Identification Number) of Mankind Life Sciences is U24100DL2020PTC369904. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mankind Life Sciences has 6 court cases on record: 5 filed by the company and 1 filed against it. 3 are pending. Most are in the high courts.
Mankind Life Sciences was incorporated on 14 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Mankind Life Sciences has 5 deals on record (2 rights issues, 2 funding rounds, 1 secondary share transfer), with disclosed funding of ₹100 Cr; the latest was in December 2022.
Mohammad Faisal Siddiqui was appointed as Whole-Time Director on 10 Sep 2026. Meenakshi Agarwal was appointed as Director on 25 May 2026. Sanjay Koul ceased to be CEO on 01 Aug 2025. Mankind Life Sciences has 15 board changes on record in total.
Yes, Mankind Life Sciences is registered as an MSME under Udyam registration (number: UDYAM-HP-10-0006599).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages